Literature DB >> 19298852

Gamma-glutamyltransferase-dependent resistance to arsenic trioxide in melanoma cells and cellular sensitization by ascorbic acid.

Chiara Giommarelli1, Alessandro Corti, Rosanna Supino, Enrica Favini, Aldo Paolicchi, Alfonso Pompella, Franco Zunino.   

Abstract

The cell ability of tumor cells to tolerate stress conditions is a typical feature of solid tumors. In particular, the resistance to oxidative stress of melanoma cells likely contributes to their intrinsic drug resistance. In an attempt to develop novel strategies for overcoming the mechanisms of cellular protection against oxidative stress, in this study we have explored the efficacy of the combination of two prooxidant agents in two human melanoma cell clones. The selected clones are characterized by a marked difference in expression of gamma-glutamyltransferase, which is known to produce a persistent low level of oxidative stress resulting in the stimulation of protective systems. The gamma-glutamyltransferase-overexpressing clone exhibited a low susceptibility to arsenic trioxide-induced apoptosis, associated with low reactive oxygen species induction and increased catalase activity. The combination of arsenic trioxide with subtoxic concentrations of ascorbic acid resulted in a sensitization to apoptotic cell death. The expression of protective mechanisms, in particular catalase activity, accounted for the behavior of the resistant clone. The sensitization achieved by the combination was associated with a cellular response involving the ASK1/p38 axis, which is implicated in the regulation of catalase expression and the activation of apoptotic signals. In conclusion, the results of our study provide evidence that a rational combination of prooxidant agents may be effective in overcoming cellular tolerance to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298852     DOI: 10.1016/j.freeradbiomed.2009.03.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

2.  Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Authors:  Serkan Sertel; Margaret Tome; Margaret M Briehl; Judith Bauer; Kai Hock; Peter K Plinkert; Thomas Efferth
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

3.  Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.

Authors:  Mona Dawood; Sami Hamdoun; Thomas Efferth
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

4.  Antitumoral effects of pharmacological ascorbate on gastric cancer cells: GLUT1 expression may not tell the whole story.

Authors:  Alessandro Corti; Eugenia Belcastro; Alfonso Pompella
Journal:  Theranostics       Date:  2018-11-15       Impact factor: 11.556

5.  Biochemical clinical factors associated with missed abortion independent of maternal age: A retrospective study of 795 cases with missed abortion and 694 cases with normal pregnancy.

Authors:  Jie Fang; Bing Xie; Binghai Chen; Chen Qiao; Bo Zheng; Xiaojin Luan; Jiajia Liu; Yidan Yan; Qianwen Zheng; Min Wang; Wanyin Chen; Zeyu He; Cong Shen; Hong Li; Xia Chen; Jun Yu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 6.  High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.

Authors:  Franziska Böttger; Andrea Vallés-Martí; Loraine Cahn; Connie R Jimenez
Journal:  J Exp Clin Cancer Res       Date:  2021-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.